“…Initial research has begun to establish the link between social risk factors and the results of clinical trials, suggesting that these factors may compromise trial efficacy [ 13 , 14 ]. However, the evidence for these assertions remains limited primarily due to the inconsistent capture and reporting of SDoH in research studies [ 11 , 15 – 17 ] Furthermore, scoping reviews have consistently indicated a significant gap in reporting social determinants, such as race, ethnicity, and demographic characteristics within the clinical and translational research literature [ 3 , 9 , 16 , 18 ].…”